X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
oncology (55) 55
female (50) 50
male (42) 42
middle aged (41) 41
adult (38) 38
aged (35) 35
index medicus (35) 35
pharmacology & pharmacy (31) 31
chemotherapy (28) 28
cancer (26) 26
pharmacokinetics (22) 22
article (20) 20
human necessities (18) 18
hygiene (18) 18
medical or veterinary science (18) 18
medicine & public health (18) 18
preparations for medical, dental, or toilet purposes (18) 18
dose-response relationship, drug (17) 17
mice (17) 17
pharmacology/toxicology (17) 17
animals (16) 16
clinical trials (16) 16
investigating or analysing materials by determining theirchemical or physical properties (16) 16
measuring (16) 16
neoplasms - drug therapy (16) 16
physics (16) 16
testing (16) 16
treatment outcome (16) 16
aged, 80 and over (15) 15
care and treatment (15) 15
research (15) 15
antineoplastic agents - pharmacokinetics (14) 14
antineoplastic agents - therapeutic use (14) 14
infusions, intravenous (13) 13
antineoplastic agents - adverse effects (12) 12
biochemistry (12) 12
cancer research (12) 12
microbiology (11) 11
antineoplastic agents - administration & dosage (10) 10
area under curve (10) 10
beer (10) 10
chemistry (10) 10
compositions or test papers therefor (10) 10
condition-responsive control in microbiological orenzymological processes (10) 10
enzymology (10) 10
measuring or testing processes involving enzymes, nucleicacids or microorganisms (10) 10
metallurgy (10) 10
mutation or genetic engineering (10) 10
organic chemistry (10) 10
peptides (10) 10
processes of preparing such compositions (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
spirits (10) 10
vinegar (10) 10
wine (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
phase-ii (9) 9
stem cells (9) 9
breast cancer (8) 8
child (8) 8
cisplatin (8) 8
drug therapy (8) 8
gene expression (8) 8
hematology (8) 8
maximum tolerated dose (8) 8
pharmacology (8) 8
toxicity (8) 8
tumors (8) 8
breast-cancer (7) 7
electrotherapy (7) 7
leukemia (7) 7
magnetotherapy (7) 7
radiation therapy (7) 7
resistance (7) 7
therapy (7) 7
time factors (7) 7
ultrasound therapy (7) 7
adolescent (6) 6
antimitotic agents (6) 6
antineoplastic agents (6) 6
biochemistry & molecular biology (6) 6
breast neoplasms - drug therapy (6) 6
child, preschool (6) 6
children (6) 6
chromatography, high pressure liquid (6) 6
deoxycytidine - analogs & derivatives (6) 6
medicine, research & experimental (6) 6
neoplasms - metabolism (6) 6
oncology, experimental (6) 6
oxaliplatin (6) 6
p-glycoprotein (6) 6
paclitaxel (6) 6
pharmacodynamics (6) 6
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (6) 6
ribonucleotide reductase (6) 6
solid tumors (6) 6
trial (6) 6
young adult (6) 6
administration, oral (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. 1137 - 1145
Background Vinorelbine has demonstrated anticancer activity and is primarily metabolized in the liver. This single‚Äźinstitution, phase I pilot study describes... 
Liver dysfunction | Indocyanine green | Safety | Pharmacokinetics | Vinorelbine | TRIAL | ONCOLOGY | CLINICAL PHARMACOKINETICS | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 432 - 432
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 2544 - 2544
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 3365 - 3365
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 11/2015, Volume 76, Issue 5, p. 897
The California Cancer Consortium completed a phase I trial of E7389 (eribulin mesylate), an analog of the marine natural product halichondrin B. This trial was... 
Care and treatment | Clinical trials | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6_suppl, pp. 142 - 142
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 03/2009, Volume 106, Issue 13, pp. 5394 - 5399
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 11/2013, Volume 72, Issue 5, p. 1089
Everolimus, an oral inhibitor of mammalian target of rapamycin, can augment the efficacy of HER inhibitors in preclinical studies. This study was conducted to... 
Antimitotic agents | Care and treatment | Cancer patients | Oncology, Experimental | Research | Antineoplastic agents | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.